Nutritional Regulators of Bcl-xL in the Brain

被引:13
|
作者
Park, Han-A [1 ]
Broman, Katheryn [1 ]
Stumpf, Allison [1 ]
Kazyak, Sara [1 ,2 ]
Jonas, Elizabeth A. [3 ]
机构
[1] Univ Alabama, Dept Human Nutr & Hospitality Management, Coll Human Environm Sci, Tuscaloosa, AL 35487 USA
[2] Univ Alabama, Dept Biol Sci, Coll Arts & Sci, Tuscaloosa, AL 35487 USA
[3] Yale Univ, Dept Internal Med, Endocrinol Sect, New Haven, CT 06520 USA
来源
MOLECULES | 2018年 / 23卷 / 11期
关键词
Bcl-xL; mitochondria; neuroprotection; nutrients; DEPENDENT ANION CHANNEL; NEURAL STEM-CELLS; AMYLOID PRECURSOR PROTEIN; CEREBRAL-ARTERY OCCLUSION; MODERATE ALCOHOL-CONSUMPTION; OUTER MITOCHONDRIAL-MEMBRANE; ISCHEMIA-REPERFUSION INJURY; ESTROGEN-RECEPTOR-ALPHA; CYTOCHROME-C RELEASE; DOCOSAHEXAENOIC ACID;
D O I
10.3390/molecules23113019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
B-cell lymphoma-extra large (Bcl-xL) is an anti-apoptotic Bcl-2 protein found in the mitochondrial membrane. Bcl-xL is reported to support normal brain development and protects neurons against toxic stimulation during pathological process via its roles in regulation of mitochondrial functions. Despite promising evidence showing neuroprotective properties of Bcl-xL, commonly applied molecular approaches such as genetic manipulation may not be readily applicable for human subjects. Therefore, findings at the bench may be slow to be translated into treatments for disease. Currently, there is no FDA approved application that specifically targets Bcl-xL and treats brain-associated pathology in humans. In this review, we will discuss naturally occurring nutrients that may exhibit regulatory effects on Bcl-xL expression or activity, thus potentially providing affordable, readily-applicable, easy, and safe strategies to protect the brain.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Akt and Bcl-xL are independent regulators of the mitochondrial cell death pathways
    DAVIDRPLAS
    JEFFREYCRATHMELL
    CRAIGBTHOMPSON
    Cell Research, 2002, (Z1) : 276 - 277
  • [2] Pulling the plug on BCL-XL
    Paul S Jeng
    Emily H Cheng
    Nature Chemical Biology, 2013, 9 : 351 - 352
  • [3] The Structural Biology of Bcl-xL
    Lee, Erinna F.
    Fairlie, W. Douglas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [4] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    Yoshimine, S.
    Kikuchi, E.
    Kosaka, T.
    Mikami, S.
    Miyajima, A.
    Okada, Y.
    Oya, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2312 - 2320
  • [5] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    S Yoshimine
    E Kikuchi
    T Kosaka
    S Mikami
    A Miyajima
    Y Okada
    M Oya
    British Journal of Cancer, 2013, 108 : 2312 - 2320
  • [6] The role of the C-terminal membrane anchor domain of Bcl-XL in heterodimerization of Bcl-XL and Bax
    Jeong, SY
    Hsu, YT
    Lee, YJ
    Sharpe, J
    Motoshi
    Suzuki
    Youle, RJ
    FASEB JOURNAL, 2003, 17 (05): : A1004 - A1005
  • [7] Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-XL
    Mendez, Olga
    Martin, Berta
    Sanz, Rebeca
    Aragues, Ramon
    Moreno, Victor
    Oliva, Baldo
    Stresing, Verena
    Sierra, Angels
    CARCINOGENESIS, 2006, 27 (06) : 1169 - 1179
  • [8] NSAIDs Downregulate Bcl-XL and Dissociate BAX and Bcl-XL to Induce Apoptosis in Colon Cancer Cells
    Bank, Alexander
    Yu, Jian
    Zhang, Lin
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2008, 60 : 98 - 103
  • [9] Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission
    Hickman, John A.
    Hardwick, J. Marie
    Kaczmarek, Leonard K.
    Jonas, Elizabeth A.
    JOURNAL OF NEUROPHYSIOLOGY, 2008, 99 (03) : 1515 - 1522
  • [10] The Subcellular Expression Patterns of Bcl-Xl in Primary Brain Tumour Samples
    Vassiliou, A.
    Alavian, K.
    Tsujishita, M.
    Bae, H.
    BRITISH JOURNAL OF SURGERY, 2021, 108 (SUPPL 2)